Skip to main content
. 2019 Dec 5;96(3):E377–E386. doi: 10.1002/ccd.28642

Table 1.

Baseline patient characteristics

No PAD 682 (85%) PAD 119 (15%) p‐value
Age, (years) mean ± SD 82.4 ± 6.2 81.9 ± 6.1 .45
Women 338 (49.6%) 53(44.5%) .31
Weight 73.9 ± 16.5 75.0 ± 17.5 .51
Logistic EuroSCORE (%) mean ± SD 17.0 ± 10.1 17.3 ± 10.9 .72
CKD
No CKD 305 (44.7%) 59 (49.6%)
GFR 30–59 ml/min 343 (50.3%) 54 (45.4%) .60
GFR <30 ml/min 34 (5.0%) 6 (5.0%)
Diabetes 188 (27.6%) 50 (42.0%) .001
Prior CVA/TIA 67 (9.9%) 16 (13.5%) .24
COPD 127 (18.6%) 28 (23.5%) .82
CAD 328 (48.1%) 76 (64.4%) .001
Prior MI 97 (14.4%) 19 (16.1%) .62
Prior AF 399 (58.5%) 71 (59.7%) .81
Prior VT 17 (2.6%) 3 (2.7%) .95
Previous CABG 99 (14.5%) 17 (14.3%) .95
Previous BAV 52 (7.6%) 8 (6.7%) .73
LVEF
≤35% 89 (13.1%) 15 (12.6%)
35–49% 110 (16.2%) 13 (10.9%) .31
≥50% 480 (70.7%) 91 (76.5%)

Abbreviations: AF, atrial fibrillation; BAV, balloon aortic valvuloplasty; CABG, coronary artery bypass grafting; CAD, coronary artery disease; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; CVA, cerebrovascular accident; DM,diabetes mellitus; EuroSCORE, European System for Cardiac Operative Risk Evaluation score; LVEF, left ventricular ejection fraction; MI, myocardial infarction; N/A, not available; NDM, no diabetes mellitus; PAD, peripheral arterial disease; SD, standard deviation; TAVR, transcatheter aortic valve replacement; TIA, transient ischemic attack; VT, ventricular tachycardia.